Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies (2019)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1111/bjh.15685
- Subjects: LINFOMA; TRANSPLANTE HOMÓLOGO; CÉLULAS-TRONCO; NEOPLASIAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: British journal of haematology
- ISSN: 0007-1048
- Volume/Número/Paginação/Ano: v. 184, n. 4, p. 547-557, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BRIERLEY, Charlotte K et al. Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies. British journal of haematology, v. 184, n. 4, p. 547-557, 2019Tradução . . Disponível em: https://doi.org/10.1111/bjh.15685. Acesso em: 28 maio 2024. -
APA
Brierley, C. K., Jones, F. M., Hanlon, K., Peniket, A. J., Hatton, C., Collins, G. P., et al. (2019). Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies. British journal of haematology, 184( 4), 547-557. doi:10.1111/bjh.15685 -
NLM
Brierley CK, Jones FM, Hanlon K, Peniket AJ, Hatton C, Collins GP, Schuh A, Medd P, Clark A, Ward J, Rocha VG. Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies [Internet]. British journal of haematology. 2019 ; 184( 4): 547-557.[citado 2024 maio 28 ] Available from: https://doi.org/10.1111/bjh.15685 -
Vancouver
Brierley CK, Jones FM, Hanlon K, Peniket AJ, Hatton C, Collins GP, Schuh A, Medd P, Clark A, Ward J, Rocha VG. Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies [Internet]. British journal of haematology. 2019 ; 184( 4): 547-557.[citado 2024 maio 28 ] Available from: https://doi.org/10.1111/bjh.15685 - Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis
- Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
- Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria
- Duffy null genotype or Fy(a-b-) phenotype are more accurate than self-declared race for diagnosing benign ethnic neutropenia in Brazilian population
- Prevalence of SMIM1 c.64_80del17 homozygotes in southeastern Brazil [Carta]: the Vel-negative phenotype
- Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
- Current role of interferon in hairy cell leukemia therapy: a timely decision
- Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.[Carta]
- Survival among children and adults treated with granulocyte transfusions: twenty years' experience at a Brazilian blood center
- The impact of low dose busulfan on gonodal function after allogeneic hematopoietic stem cell transplantation for aplastic anemia [Carta]
Informações sobre o DOI: 10.1111/bjh.15685 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
